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Abstract
Objective In primary care, clinically recommended drug
medication is often modified after hospitalization. The aim
of the study was to examine the frequency and factors
associated with GPs changing the hospital drug treatment in
a sample of patients discharged from the hospital.
Methods In a prospective study, the prehospital, hospital
and posthospital diagnoses and drug treatment of 130
patients consecutively recruited from 15 general practices
were recorded over a period of 12 months. The ICD-10
classification was used to compare the data from hospitals
and general practices. GPs who changed the hospital drug
treatment were interviewed in a semistructured way
concerning their reasons for changing.
Results The most frequent diagnoses during and after
hospitalization were listed in the ICD-10 chapters ‘Diseases
of the cardiovascular system’ (34.3%) and ‘Endocrine,
nutritional and metabolic diseases’ (18%). Accordingly, the
most frequently prescribed drug medication was related to
these chapters (47.5% and 15.9%, respectively). Hospital-
ization led to a significant increase in the number of drugs
per patient [prehospital 5.4; hospital 6.6; posthospital 6.7;
(p<0.001)]. GPs changed the hospital drug recommenda-
tions of the discharge letters in 60.7% of the cases. They
omitted drugs in 27.6%, replaced prehospital drug medica-
tion in 26.3%, changed to other manufacturers in 9.3%,
added new drugs in 13.1% and changed the dosage in 4.2%
of the cases. Changes in drug medication correlated
significantly with the number of drugs and number of
diagnoses (p<0.001). The most frequently mentioned
reason for drug changing by GPs was cost savings
(30.3%). But more often they changed drug medication
for patient-related reasons (42.4%): ‘better individual drug
effect’ in 18.5%, ‘no reasonable indication’ in 17.1% and
‘not related to adequate diagnosis’ in 6.8% of the cases.
Conclusion After hospital discharge, GPs changed more
than half of posthospital drug recommendations. Although
they believed that economical aspects were the most
important reason for their behavior, most drug changes
were done for patient-related reasons.
Keywords Hospital discharge . General practitioners .
Drug utilization . Out-patient prescriptions
Introduction
In Germany, as in other industrial countries in Europe and
overseas, health administrators of the government try to
save health system costs by restriction of drug prescription
in family practices. Hereby, the most important instrument
to slow down the increase in drug costs is economical
awareness of drug prescribing among general practitioners
(GP) (Bijl et al. 1998; Hakansson et al. 2001).
However, the combined physician-patient decisions for
prescribing or changing drug medication are too complex to
reduce to economical aspects. In particular, GPs have to
regard various patient-related factors, such as disease-
specific indication, patient shared decisions, side effects,
drug interactions and so on.
A high percentage of drug changes results at the
hospital-general practice interface. Therefore, this topic is
particularly suitable for researching the drug prescribing
behavior of GPs. Former studies have found that GPs
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change hospital written drug medication in 34–82% of
discharged patients (Cochrane et al. 1992; Burns et al.
1992; Feely et al. 1999). However, most studies were
performed many years ago and lost their actuality through
rapid changes in health system government declarations.
Moreover, interpretation of the results to Germany is
limited, because studies resulted from other countries (US,
Great Britain, Switzerland) with modified health systems.
The study was undertaken to examine actual frequencies
and reasons for changing drug medication after hospitali-
zation in primary care in Germany. We aimed, in particular,
to identify GPs prescribing decisions for changing clinically
recommended posthospital drug medication.
Subjects and methods
Sampling
Fifteen primary care practices in Germany participated in
this prospective study. All practices consecutively collected
posthospital discharge letters for a period of 12 months
from January 2004 to January 2005. Patient criteria for
inclusion in the study were the presence of a preliminary or
final discharge letter of an internal medical ward of a
district general hospital and the diagnosis of at least one
chronic disease.
Out of a group of 20 GPs involved in educational
programs at the University of Heidelberg who were asked
to participate in the study, 16 GPs (80%), 2 females and 14
males, took part. The sample represents a diversity of
practice size and location (rural, urban). The age of GPs
was uniformly distributed (40–50 years, n=5; 50–60 years,
n=5; >60 years, n=5).
Data source and statistical analysis
Drug medication and related diagnoses were recorded three
times for all included patients. Prehospital data and the
actual posthospital data were taken by reviewing practice
patient documents prior to referral to the hospital and after
discharge. Data from the last GP consulting before the
referral and from the first after the discharge were used in
each case. Hospital data were recorded from the hospital
discharge letter. The frequency of GP drug cancellation,
replacement, and dosage alteration was recorded by
comparison of the hospital drug recommendations in the
discharge letter with the actual drug medication as received
from practice patient documents. Drugs for complementary
medicine were not considered in this study because they are
not listed in the German drug manual.
All diagnoses were coded according to the International
Classification of Diseases (ICD-10 2007). For statistical
analysis, drug medication (trade name, generic drug,
dosage) was filed under the 22 main ICD-10 chapters as
listed in the German drug manual (Rote Liste® 2004). If a
drug could be assigned to more than one ICD-10 chapter,
the chapter for its usual clinical indication was always
chosen. For example, hydrochlorothiazide was filed exclu-
sively under chapter 9 (cardiovascular diseases) and not
under chapter 18 (symptoms and clinical abnormalities).
After recording patients’ data in a semistructured interview,
GPs who changed the hospital drug treatment were asked
about their reasons for changing medication proposed by
the hospital. Prior to the study, the structure of the interview
was discussed in a focus group.
All statistical procedures were performed with SAS
software. Bivariate comparisons for variables were con-
ducted using Pearson’s chi-square test and Student’s t test
for categorical and continuous variables. A two-sided P
value <0.05 was considered to indicate statistical signifi-
cance. A multivariable logistic regression model was used
to obtain the association between variables and drug
changing.
Results
A total of 130 patients were enrolled in the study (68 females,
62 males). The mean age was 71 years (range 19–97). The
females (75 years, range 24–97) were 7 years older than male
patients (68 years, range 19–86). Eighty-three percent of the
patients contacted their GP within the first 4 days after
discharge from the hospital; 11% of the patients visited the
practice after 5–10 days.
Prehospital, hospital, and posthospital diagnosis groups
Summarizing the discharge letters and practice patient
documents resulted in 1,503 diagnoses (753 hospital
diagnoses and 750 practice patient diagnoses). The number
of diagnoses significantly increased with age from 5 in
patients <70 years to 6.5 in patients >70 years, but there
was no difference between males and females. In the
statistical analysis from a total of 22 ICD chapters of the
drug manual, only 18 chapters were registered.
The most frequent diagnoses on referral to the hospital
were filed under chapter 18, ‘Symptoms and clinical and
laboratory abnormalities’ (females 16.9%, males 8.5%, total
25.4%). Of the patients, 12.3% were registered in chapter 0,
‘No diagnosis.’ All diagnoses are summarized in this
chapter that were not related to one of the other chapters,
for example, diagnostic examination, improvement of
pharmacological treatment or follow-up procedures. When
patients of chapter 18 and 0 were added, a total of 37.7%
patients were referred to the hospital without an exactly
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described diagnosis (Fig. 1). Second to the most frequent
referral diagnoses, ‘diseases of cardiovascular system’ were
listed with 23.8%. Further reasons for referral were
‘diseases of the respiratory system’ with a frequency of
10% followed by ‘diseases of digestive system’ with 7.7%.
‘Diseases of the musculo-skeletal system’ and ‘psychological
disorders’ were not diagnosed for referral to an internal
medical ward of hospital.
As a result of hospital stay, diagnoses of chapter 0
completely disappeared after discharge, and the number of
diagnoses of chapter 18 decreased from 25.4% to 2.8%
(Fig. 1). The ranking of hospital letter diagnoses was now
led by diagnoses of chapter 9, ‘Diseases of the cardiovas-
cular system’ (37.3%), followed by ‘endocrine, nutritional
and metabolic diseases’ (19.5%), ‘diseases of digestive
system’ (8.2%) and ‘diseases of respiratory system’ (6.2%).
In the posthospital practice document analysis ‘diseases of
the musculo-skeletal system’ and ‘psychological disorders’
rose to the third and fourth ranking positions. The number of
‘diseases of the musculo-skeletal system’ increased signifi-
cantly from 3.9% to 12% (p<0.05). Also, ‘psychological
disorders’ were registered significantly more commonly in
practices than in hospitals (9.2% vs. 5.8%, p<0.05).
Prehospital, hospital, and posthospital drug medication
A total of 2,427 drugs were recorded, on average 6.5 per
patient. The hospitalization led to a significant increase of
1.3 drugs per patient (p<0.001).
Corresponding to the high frequency of diagnoses, most
drugs were prescribed for chapter 9, ‘Diseases of cardio-
vascular system’ (47.5%). Similar to the ranking of
diagnoses, drug medication follows for treatment of
‘endocrine, nutritional and metabolic diseases’ with 15.9%
and ‘diseases of digestive system’ with 7.7% (data not
shown). Figure 2 depicts a significant increase in the drug
number prior to and after hospitalization in the three
chapters of most frequently prescribed drugs and addition-
ally in chapter 1 (infectious diseases, i.e., antibiotics).
According to the frequency of diagnoses, patients received
drugs for treatment of ‘diseases of the musculo-skeletal
system’ and ‘psychological disorders’ significantly more
often in practices than in hospitals.
In the practice setting, only 19.4% of the proposed
hospital drug medication was issued unchanged. GPs
changed the hospital drug recommendations of the dis-
charge letters in 60.7% of the cases. They omitted drugs in
27.6%, replaced prehospital drug medication in 26.3%,
changed to other manufacturers in 9.3%, added new drugs
in 13.1% and changed the dosage in 4.2% of the cases
(Fig. 3).
Because cardiovascular drugs of chapter 9 were most
frequently prescribed and changed; a more detailed listing
of its pharmacological subgroups is shown in the table. This
indicates that most changes are related to antihypertensive
and cardiac drugs. Considering 2,427 recorded drugs and a
total of 1,050 posthospital drug changes, an even more
detailed portrayal at the level of pharmacological subgroups
or even single agents would generate more confusion than
providing worthwhile information.
Reasons for drug changing
The most frequent reason for changing clinically recom-
mended drug medication from interviewees was cost
savings (30.3%). However, GPs stated ‘better individual
drug effect’ in 18.5%, ‘no reasonable indication’ in 17.1%,
‘use up prehospital prescribed drugs’ in 8.1% and ‘not
related to adequate diagnosis’ in 6.8% of the cases.
Summarizing these statements, patient-related reasons
would be responsible for 42.4% of all drug changes after
hospital discharge (Fig. 4).
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We used multivariate analysis to identify patient charac-
teristics associated with drug changing. The following
variables were added to the regression equation to adjust
the probability of drug changing estimates: age, gender,
number of drugs, as well as the number of diagnoses.
Regression analysis showed that changes in drug medica-
tion correlated significantly with the number of drugs and
number of diagnoses (p<0.001), but not with patients’ age
or gender.
Discussion
The International Classification of Primary Care (ICPC) is
used in most primary care studies nowadays. The ICPC
allows classification of the reasons for encounter from the
patient’s perspective and the problems and diagnoses from
the health-care provider’s view. However, the International
Classification of Diseases (ICD-10) was chosen for our
study, because in Germany the ICD-10 is the standard
coding system of the hospitals and practices and therefore
suitable for comparing statistics and deduction of both
settings.
A total of 1,503 diagnoses were collected in 18 out of 22
ICD-10 chapters. Despite a nearly identical number of
prehospital and posthospital diagnoses, the hospital stay led
to a distinct floating of diagnoses within the different ICD-
10 chapters. It was not surprising that chapter 18 and
chapter 0 containing no exactly described diagnoses or no
diagnoses disappeared after hospital discharge, because
diagnostic or therapeutic insecurity influenced GPs to refer
patients to the hospital. Also, in agreement with numerous
primary care studies, cardiovascular diseases, digestive
diseases and respiratory disorders were the most frequent
diagnosis groups requiring admission to the hospital
(Himmel et al. 1996; Lau et al. 1999). Since the discharge
letter of an internal medical ward was a criterion of our
study, no cases of diseases of the musculo-skeletal system
and psychological disorders were listed as the reason for
referring a patient to the hospital. However, it is conspic-
uous that those diagnoses that were significantly more
common posthospital were listed in practice patient docu-
ments and in hospital discharge letters. Obviously, during a
stay in internal medical wards, patients and doctors have
less awareness of those complaints and diseases than in
primary care practice. Also, in discharge letters little
attention was given to diagnoses and nonoral medication
of eyes, skin and airways.
To compare the amount and frequency of drug changing
during and after hospital stay, patient medication in our
study was categorized according to ICD chapters. Hospi-
talization led to a 22% increase in the number of drugs per
patient after discharge. Several surveys investigating
changes in prescription at the hospital-general practice
interface resulted in a similar increase in drug number after
discharge (Himmel et al. 1996; Omori et al. 1991). In a
German single practice study, 18% more drugs were
prescribed posthospital compared to the time before
hospital admission (Himmel et al. 1996). In contrast, in a
study of geriatric patients, Nikolaus et al. (1996) described
a significantly lower number of drug prescriptions on
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discharge compared to admission. However, this study
focused on elderly patient problems with polypharmacy and
drug non-compliance, and reducing the number of drugs
was considered to be a way to prevent patient confusion
about the drug regimen.
Prescription of more drugs mostly leads to higher costs.
Results of studies in Germany, The Netherlands, Great
Britain and Sweden suggest that referral to consultants or
hospitals results in higher costs compared to general
practice (Feely et al. 1999; Bijl et al. 1998; Hakansson et al.
2001). However, prescribing of not only more but also
more expensive drug medication in hospitals must not mean
an uneconomic prescribing behavior of hospital physicians.
At least a part of the increase in costs may be caused by a
change of diagnoses. According to Bijl et al. (1998),
referral to a consultant leads in about half of the patients
to a change in diagnosis and to a 23% increase in costs.
While a higher number and more defined diagnoses may
explain an increase in costs on the one hand, on the other
hand, certain diseases require more costly medication. For
example, inpatient triple eradication therapy is very
expensive and must often be continued for some time in
the practice setting.
According to the high medical and economic impor-
tance, drugs for treatment of cardiovascuIar diseases in
hospitals as well as primary care practices are the most
frequently prescribed medication. Within the group of
cardiovascular diseases, hypertension and hyperlipidemia
are the most common disorders causing chronic drug usage
(Katz et al. 1996; Lau et al. 1999; Harder S et al. 1998;
Saltman et al. 2005). In our study, cardiovascuIar drugs
were also the superior class of drugs that have been
prescribed and changed during and after hospitalization.
However, cardiovascular drug changes in many cases are
neither caused by guideline adherence nor suggest inappro-
priate prescribing by GPs. Himmel et al. (2004) found
changes of about 30% in antihypertensive and cardiac drugs
after hospital admission independent of whether the patient
was admitted because of cardiac disease or other medical
problem. In a 1-year follow-up study, about 50% of all
cardiovascular prescriptions were subject to changes in the
choice of preparation (brand-generic) or within classes of
similar agents prescribed (Harder et al. 2005). In a study by
Katz et al. (1996), treatment changes were almost as
common in patients admitted with stable cardiovascular
disease as in those requiring rapid drug intervention. GPs’
decisions for posthospital changing of cardiovascular drugs
in the practice setting possibly could depend on the kind of
cardiovascular disease. While antihypertensive agents will
more often be changed in patients with heart failure, the
treatment regime remained stable 2 weeks after discharge
(Scherer et al. 2006).
As expected, hospital admission encouraged an increase
in drugs for the treatment of digestive diseases, particularly
H2-receptor antagonists and proton pump inhibitors.
According to Nardino et al. (2000), in approximately 50%
of admitted patients acid-suppressive therapy is started
inappropriately during hospitalization. Sometimes home
GPs retain antacid prescriptions after discharge and not
rarely it results in acid-suppressive long-term treatment
(Zink et al. 2005).
GPs changed the hospital drug recommendations of the
discharge letters in more than half the cases. About one
third of the interviewees mentioned costs as the most
important argument for changing the prescribed drugs. In a
German questionnaire study even 58% of GPs stated
economical considerations as the most important reason
for changing drug medication followed by patient-related
reasons in 34% (Roth-Isigkeit and Harder 2005). Numerous
reimbursement restrictions of health system facilities might
explain these prescription habits of German GPs. In our
study, however, when the different patient-related answer
categories for GPs’ decisions for drug changing were
summarized, more than half of all interview answers
concerned patient-related reasons. Probably this rate is still
higher, because the interview category ‘other’ contained
further patient-related reasons such as patient-shared deci-
sions or me-too prescriptions. GPs considered patient-related
Table 1 Changes of cardiovascular drugs after discharge from hospital, arranged according to pharmacological subgroups (n=481)
Drugs
omitted
Return to
prehospital
prescription
Hospital
drug
continued
New drug
added
Manufacturer
changed
Dose
changed
n % n % n % n % n % n %
Anticoagulants, platelet function inhibitors 35 7.2 14 2.9 15 3.1 4 0.8 2 0.4 0 0.0
Antihypertensive drugs, diuretics 44 9.1 44 9.1 38 7.9 30 6.2 23 4.8 6 1.2
Beta-receptor blockers, calcium channel antagonists,
ACE inhibitors
43 9.1 44 9.1 31 6.4 25 5.2 30 6.2 14 2.9
Other cardiac substances, vasoactive agents 12 2.5 10 2.0 13 2.7 3 0.6 1 0.2 0 0.0
Total 134 27.8 112 23.3 97 20.1 62 12.9 56 11.6 20 4.1
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reasons obviously as less important for the reason for
prescription; in the interview, however, they named appro-
priate categories more often than cost savings. We do not
believe that this explains the low rate of generic drugs
prescribed by GPs posthospital in our study, which is
probably more due to the currently high acceptance of
generic prescribing in hospitals.
It was not the aim of the study to record how often
hospital doctors change the medication of GPs. However, at
the first posthospital practice encounter, GPs returned to
patients’ prehospital prescription in 26.3% of cases. There
is no detailed information on why they did so, but this
should not be misinterpreted as suspicion of medical
competence of hospitals. Taking into account the common
GPs’ interview statements, “better individual drug effect”
and “no reasonable indication,” it rather seemed to show
GPs’ very differentiated and individual view of their
patients’ therapeutic needs. Even in 4.1% of cases,
symptoms and ailments obviously required additional
newly prescribed drug medication (“new indication”).
GPs’ drug changes on hospital discharge appeared to be
induced not only by principles of rational prescribing, but
also most notably by comprehensive knowledge and
competence in long-term care of their patients. For
example, deficits have been shown concerning guideline
implementation of medical heart failure treatment into
practice (Peters-Klimm et al. 2008). Armstrong et al.
(1996) identified three models explaining the drug pre-
scribing behavior of GPs. Besides traditional agencies of
change with an accumulation of evidence-based informa-
tion, important factors influencing prescribing behavior are
therapeutic challenges like successful treatment or conflic-
tual clinical events. Further studies on this topic are
necessary to suggest which of these single or combined
mechanisms are responsible for GPs’ decisions for chang-
ing hospital-recommended prescriptions. We feel that the
latter two reasons play a particularly important role in the
GP’s subjective prescription decision.
Our study is limited by the fact that a heterogeneous
sample of 15 GPs by chance was recruited, but not in a
random manner. However, the age and gender structure of
patients and doctors in this study is very similar to that of
numerous studies concerning problems of drug medication
in primary care practice (Himmel et al. 1996; Cochrane
et al. 1992; Burns et al. 1992). Therefore, our findings
cannot be considered as representative, but nevertheless
characteristic of GP prescribing behavior nationwide.
In conclusion, the data of our study suggest that drug
medication is still changed too frequently and extensively at
the interface between clinical pharmacology and primary
care practice. This situation is unsatisfactory for patients
and physicians and may lead to unnecessary and avoidable
costs for the health-care system. Better communication
between hospital and practicing physicians is easy to
postulate, but difficult to realize. The concept of shared
care, at present, failed to demonstrate significant benefits
for patients apart from improved prescribing (Smith et al.
2007). However, in Germany it is far from reality and
difficult to put into practice. Besides improvement in
communication between family and hospital doctors via
transmission of more detailed information about drug
changes to the discharge medication list (Clintborg et al.
2007; Gonski et al. 1993), perhaps more patient informa-
tion, such as pharmaceutical counseling and better inform-
ing of patients concerning their pharmaceutical care plan,
might be helpful to reduce posthospital drug prescribing
(Al-Rashed et al. 2002; Sorensen et al. 2004). Furthermore,
use of modern media like the world-wide web in primary
care practices opens up new possibilities for better
maintenance of adequate drug treatment after hospital
discharge. See Table 1.
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